Picture EBD Group Biotech Showcase 2024 San Francisco 650x100px

News > All

Total search results: 5466 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 53 54 55  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Qiagen N.V.. (9/25/23). "Press Release: Qiagen Enhances QIAwave Portfolio with New Eco-friendlier Nucleic Acid Extraction Kits". Venlo. 2023-09-25
Traceless Materials GmbH. (9/25/23). "Press Release: Traceless Materials Secures €36.6 Million Series A to Build First Industry Plant for Bio-circular Alternative to Plastic". Hamburg. 2023-09-25
Valneva S.E.. (9/25/23). "Press Release: Valneva Announces New Ixiaro Supply Contract with the U.S. Government Worth a Minimum of $32 Million". Saint Herblain. 2023-09-25
Eckert & Ziegler AG. (9/25/23). "Press Release: Eckert & Ziegler Signs Strategically Important Agreement for the Supply of Lutetium-177 with POINT Biopharma". Berlin. 2023-09-25
Max-Delbrück-Centrum für Molekulare Medizin (MDC). (9/21/23). "Press Release: Starting Up with Highly Promising Immunotherapies". 2023-09-21
Bayer AG. (9/21/23). "Press Release: Bayer to Collaborate with Hologic in Breast cancer Imaging [Not intended for U.S. and UK Media]". Berlin. 2023-09-21
Transimmune AG. (9/20/23). "Press Release: Transimmune Secures $5m Funding to Enhance mRNA Vaccination with Novel Dendritic Cell Therapy". Düsseldorf. 2023-09-20
Exscientia plc. (9/20/23). "Press Release: Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany". Oxford. 2023-09-20
BenevolentAI. (9/20/23). "Press Release: BenevolentAI Signs Strategic Collaboration with Merck". London. 2023-09-20
Merck KGaA. (9/20/23). "Press Release: Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery [Not intended for US-, Canada- or UK-based media]". Darmstadt. 2023-09-20
Thermosome GmbH. (9/19/23). "Press Release: Thermosome Establishes High-Profile Clinical Advisory Board". Munich. 2023-09-19
BeiGene, Ltd.. (9/19/23). "Press Release: BeiGene Strengthens Global Portfolio and Regains Full Rights from Novartis for Anti-PD-1 Antibody Tevimbra (tislelizumab)". Basel & Beijing & Cambridge, MA. 2023-09-19
Galapagos N.V.. (9/19/23). "Press Release: Galapagos Appoints Simon Sturge to Its Board of Directors". Mechelen. 2023-09-19
Rentschler Biopharma SE. (9/19/23). "Press Release: Rentschler Biopharma Appoints Benedikt von Braunmuehl as Chief Executive Officer". Laupheim, Stevenage & Milford, MA. 2023-09-19
Broken String Biosciences Ltd.. (9/18/23). "Press Release: Broken String Biosciences Closes $15M Series A Funding Round". Cambridge. 2023-09-18
Bruker Corporation. (9/18/23). "Press Release: Bruker Introduces Novel 4D-Proteomics timsTOF Capabilities". Busan. 2023-09-18
Lonza Group AG. (9/18/23). "Press Release: Board Announcement. CEO Pierre-Alain Ruffieux to Leave Lonza – Albert M. Baehny to Step in as CEO ad interim". Basel. 2023-09-18
Atriva Therapeutics GmbH. (9/18/23). "Press Release: Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology". Tübingen & Martinsried. 2023-09-18
Adivo GmbH. (9/15/23). "Press Release: Adivo Joins Zoetis to Bring the Benefits of Species-specific Antibody Therapies to Pet Owners Worldwide". Puchheim & Munich. 2023-09-15
Scinai Immunotherapeutics Ltd.. (9/15/23). "Press Release: Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering". Jerusalem. 2023-09-15
BRAIN Biotech AG. (9/14/23). "Press Release: BRAIN Biotech AG’s Akribion Genomics Technology Receives Patent Approval for Its Groundbreaking Nuclease G-dase E". Zwingenberg. 2023-09-14
SHS Gesellschaft für Beteiligungsmanagement mbH. (9/13/23). "Press Release: Healthcare Specialist SHS Capital Announces Final Closing of Its Oversubscribed Sixth Fund Generation Totaling EUR 270 Million". Tübingen. 2023-09-13
Merck KGaA. (9/12/23). "Press Release: Merck Appoints Axel Löber as Head of Global Communications and Stakeholder Engagement". Darmstadt. 2023-09-12
Immatics N.V.. (9/11/23). "Press Release: Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics". Cambridge, MA & Tübingen. 2023-09-11
Novartis AG. (9/11/23). "Press Release: Sandoz Announces Exclusive Deal to Commercialize Biosimilar Ustekinumab". Basel. 2023-09-11
Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA. 2023-09-11
Mariana Oncology Inc.. (9/7/23). "Press Release: Mariana Oncology Announces $175 Million Series B Financing". Watertown, MA. 2023-09-07
Proteros Biostructures GmbH. (9/6/23). "Press Release: Proteros Biostructures and Orion Pharma Agree on a Long-term Multi-target Collaboration". Martinsried. 2023-09-06
Navigo Proteins GmbH. (9/6/23). "Press Release: Navigo Proteins and Nostrum Biodiscovery Announce a Research Collaboration to Enhance Affilin Ligand Discovery Using Cutting-edge AI and Molecular Modeling Techniques". Halle (Saale) & Barcelona. 2023-09-06
inContAlert GmbH. (9/6/23). "Press Release: Disruption in the Field of Incontinence. MedTech Startup inContAlert Raises EUR 1.5 Million". 2023-09-06
Scinai Immunotherapeutics Ltd.. (9/6/23). "Press Release: BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics". Jerusalem. 2023-09-06
Invios GmbH. (9/5/23). "Press Release: Invios Starts Further Clinical Trial of APN401, Novel Cell Therapy Against Solid Cancers, and Secures Major Austrian Grant Funding". Vienna. 2023-09-05
Oncgnostics GmbH. (9/5/23). "Press Release: Hong Kong Firm Invests in Jena-based Oncgnostics GmbH". Jena. 2023-09-05
iOmx Therapeutics AG. (9/5/23). "Press Release: iOmx Therapeutics Appoints Dr. Nils Peter Debus as Chief Business Officer". Martinsried. 2023-09-05
BioInnovation Institute (BII). (9/4/23). "Press Release: Six Companies Enter BioInnovation Institute’s Venture House Program Receiving Additional Financial Support". 2023-09-04
ECBF Management GmbH. (9/4/23). "Press Release: 23 Million Euros for Sustainable Packaging Materials. ECBF Leads Paptic Financing Round". Luxembourg. 2023-09-04
Bayer AG. (8/30/23). "Press Release: Strong Commitment to Modern Crop Protection Made in Europe. Bayer to Invest EUR 220 Million in New R&D Facility at Its Monheim Site". Monheim. 2023-08-30
Intellegens Ltd.. (8/30/23). "Press Release: Intellegens and CPI Awarded £1.6m Innovate UK Grant to Advance Manufacture of Oligonucleotide Therapeutics with Machine Learning". Cambridge. 2023-08-30
Bayer AG. (8/29/23). "Press Release: Gene Editing – Pairwise and Bayer Start New Five-year Multi-million Dollar Collaboration to Further Advance Short-stature Corn". Durham, NC & Monheim. 2023-08-29
T-Curx GmbH. (8/28/23). "Press Release: T-Curx GmbH Announces Appointment of Two Industry Leaders to Its Board of Directors". 2023-08-28
Eppendorf SE. (8/25/23). "Press Release: Automation of Takara Bio’s Chemistries on Eppendorf’s Automated Pipetting Systems for Significantly Higher Efficiency". San José, CA & Hamburg. 2023-08-25
BlueRock Therapeutics LP. (8/23/23). "Press Release: BlueRock’s Phase I Study with Bemdaneprocel in Patients with Parkinson’s Disease Meets Primary Endpoint". Wuppertal. 2023-08-23
AiCuris Anti-infective Cures AG. (8/23/23). "Press Release: AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of Prevymis (letermovir) in Second Indication". Wuppertal. 2023-08-23
Abivax S.A.. (8/23/23). "Press Release: Abivax Appoints Patrick Malloy as Senior Vice President Investor Relations". Paris. 2023-08-23
Rentschler Biopharma SE. (8/23/23). "Press Release: Collaboration to Improve Process Analytical Technologies and AAV Manufacturing for Gene Therapies". Stevenage, London & Laupheim. 2023-08-23
Sophia Genetics S.A.. (8/22/23). "Press Release: Sophia Genetics Expands Relationship with Gustave Roussy". Boston, MA & Rolle. 2023-08-22
Bayer AG. (8/22/23). "Press Release: Bayer Appoints Dr. Juergen Eckhardt as New Head of Pharmaceuticals Business Development & Licensing / Open Innovation". Berlin. 2023-08-22
Bico Group AB. (8/21/23). "Press Release: Maria Forss Is Appointed New President and CEO of Bico Group AB (publ)". 2023-08-21
Mysthera Therapeutics AG. (8/21/23). "Press Release: Mysthera Therapeutics Launches to Develop First-in-Class Autoimmune Disease Therapies". Basel. 2023-08-21
Bico Group AB. (8/21/23). "Press Release: Bico Announces Goodwill Impairment Predominantly Due to Increased WACC, and Write-downs of Assets". 2023-08-21
Sartorius AG. (8/17/23). "Press Release: Sartorius and Repligen Corporation Launch Integrated System with Biostat STR and XCell ATF for Upstream Process Intensification". Göttingen. 2023-08-17
Bruker Corporation. (8/17/23). "Press Release: Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction". Billerica, MA & Emeryville, CA. 2023-08-17
CureVac N.V.. (8/17/23). "Press Release: CureVac Announces Financial Results for the Second Quarter and First Half of 2023 and Provides Business Update". Tübingen & Boston, MA. 2023-08-17
BioNTech SE. (8/17/23). "Press Release: BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer". Tübingen & Boston, MA. 2023-08-17
Pieris Pharmaceuticals, Inc.. (8/17/23). "Press Release: Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals' Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific". Boston, MA. 2023-08-17
PolyPeptide Group AG. (8/15/23). "Press Release: Transformational Progress Taking Shape, Profitability Impacted by Rapid Expansion – Appointment of Marc Augustin as New CFO". Baar. 2023-08-15
BiondVax Pharmaceuticals Ltd.. (8/11/23). "Press Release: BiondVax Reports Second Quarter Financial Results and Provides Business Update". Jerusalem. 2023-08-11
Qiagen N.V.. (8/8/23). "Press Release: Qiagen Delivers Ahead of Outlook for Q2 2023 with 9% CER Sales Growth in Non-COVID Products and Updates 2023 Full-year Outlook". Venlo. 2023-08-08
Bactolife A/S. (8/8/23). "Press Release: Bactolife Raises EUR 30 Million in Series A Financing". Copenhagen. 2023-08-08
Helmholtz Zentrum München (Helmholtz Munich). (8/7/23). "Press Release: Life Science Factory to Open a New Location at Helmholtz Munich in 2024". Göttingen & Munich. 2023-08-07
Lena Biosciences, Inc.. (8/7/23). "Press Release: Lena Biosciences Appoints Dr. Eckhard von Keutz to Its Business Advisory Board and Science Advisory Board". 2023-08-07
Qiagen N.V.. (8/7/23). "Press Release: Qiagen Receives FDA Approval for Companion Diagnostic to Blueprint Medicines’ Ayvakit (avapritinib) in Gastrointestinal Stromal Tumors". Venlo & Germantown, MD. 2023-08-07
Sartorius AG. (8/3/23). "Press Release: Florian Funck Appointed CFO of Sartorius. New CFO to Take Over as of April 2024". Göttingen. 2023-08-03
Bico Group AB. (8/3/23). "Press Release: Bico Divests Berlin Property for a Total of EUR 21m". 2023-08-03
Temedica GmbH. (8/2/23). "Press Release: Temedica and AbbVie Germany Are Launching Digital Companion for Patients with Chronic Inflammatory Bowel Diseases". 2023-08-02
High-Tech Gründerfonds Management GmbH. (8/1/23). "Press Release: Bind-X Secures €10 Million in Financing as Part of Its Series B Financing Round". Martinsried. 2023-08-01
ITM Isotope Technologies Munich SE. (7/31/23). "Press Release: ITM and Point Biopharma Expand Global Supply Agreement for n.c.a. Lutetium-177". Garching & Indianapolis, IN. 2023-07-31
AaviGen GmbH. (7/26/23). "Press Release: AaviGen Raises 17 Million € in Second Financing Round to Advance Precision Gene Therapies for Heart Failure towards the Clinical Stage". Heidelberg. 2023-07-26
Qiagen N.V.. (7/26/23). "Press Release: Bio-Rad and Qiagen Announce Patent Settlement and Cross-licensing Agreement". Venlo. 2023-07-26
IZB Martinsried. (7/25/23). "Press Release: Viopas Venture Consulting Opens Office in the Innovation and Start-up Center Biotechnology (IZB)". Martinsried. 2023-07-25
Immatics N.V.. (7/24/23). "Press Release: Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb". Tübingen & Houston, TX. 2023-07-24
Epigenomics AG. (7/24/23). "Press Release: Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets". Berlin. 2023-07-24
Life Science Factory Management GmbH. (7/24/23). "Pressemitteilung: Tatjana Kasper wird neue Geschäftsführerin". Göttingen. 2023-07-24
Roche. (7/24/23). "Press Release: Roche Enters Partnership with Alnylam to Co-develop and Co-commercialise RNAi Therapeutic Zilebesiran to Treat Hypertension in Patients with High Cardiovascular Risk". Basel. 2023-07-24
Crescendo Biologics Ltd.. (7/24/23). "Press Release: Crescendo Biologics Secures $32m and Announces Expansion of CB307 Phase 1b Trial in PSMA+ Solid Tumours". Cambridge. 2023-07-24
Biotechnologie Rheinland-Pfalz (MWG RLP). (7/21/23). "Pressemitteilung: Biotechnologie-Studie. Biotechnologie hat in Rheinland-Pfalz sehr gute Zukunft - Bis 2026 stehen bis zu 800 Millionen Euro bereit". 2023-07-21
Idorsia Ltd.. (7/21/23). "Press Release: Idorsia Announces a Cost Reduction Initiative to Be Implemented by the End of 2023". Allschwil. 2023-07-21
Novartis AG. (7/20/23). "Press Release: Sandoz Announces Plans to Build a Biosimilar Technical Development Center in Slovenia to Support Future Growth of Biosimilar Pipeline". Basel. 2023-07-20
Idorsia Ltd.. (7/20/23). "Press Release: Idorsia Sells Its Asia Pacific (ex-China) Operations – Including Select License Rights to Products – to Sosei Heptares for a Total Consideration of CHF 400 Million". Allschwil. 2023-07-20
ADC Therapeutics S.A.. (7/20/23). "Press Release: ADC Therapeutics Announces Plan to Discontinue the Phase 2 LOTIS-9 Clinical Trial of Zynlonta (loncastuximab tesirine-lpyl) and Rituximab in Unfit or Frail Previously Untreated DLBCL Patients". Lausanne. 2023-07-20
LimmaTech Biologics AG. (7/20/23). "Press Release: LimmaTech Biologics Appoints Franz-Werner Haas as CEO to Lead Company into Next Stage of Corporate Growth". Schlieren. 2023-07-20
Tillotts Pharma AG. (7/20/23). "Press Release: Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis". Montréal, Munich & Rheinfelden. 2023-07-20
LimmaTech Biologics AG. (7/20/23). "Press Release: GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine". Schlieren. 2023-07-20
Sophia Genetics S.A.. (7/19/23). "Press Release: Sophia Genetics Supports Sofiva Genomics to Launch New HRD Test". Boston, MA & Rolle. 2023-07-19
Biotheus Inc.. (7/19/23). "Press Release: Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech". Zhuhai. 2023-07-19
BioGeneration Ventures B.V.. (7/19/23). "Press Release: Dr. Markus Kalousek and Dr. Andrew Lightfoot Join BGV as Venture Partners". Amsterdam. 2023-07-19
Yumab GmbH. (7/19/23). "Press Release: Yumab and InScreeneX in Joint Funding Project". Braunschweig. 2023-07-19
Pieris Pharmaceuticals, Inc.. (7/18/23). "Press Release: Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring". Boston, MA. 2023-07-18
Leon-Nanodrugs GmbH. (7/18/23). "Press Release: Leon-Nanodrugs Appoints Dr. Hans Frickel as Chief Executive Officer". Munich. 2023-07-18
Illumina, Inc.. (7/18/23). "Press Release: The Alliance for Genomic Discovery Announces Founding Biopharma Members – AbbVie, Amgen, AstraZeneca, Bayer, and Merck". San Diego, CA. 2023-07-18
SGS S.A.. (7/18/23). "Press Release: SGS Appoints Géraldine Picaud as New Chief Financial Officer [Ad hoc announcement pursuant to Art. 53 LR]". 2023-07-18
Novartis AG. (7/17/23). "Press Release: Novartis Builds on Neuroscience Pipeline and xRNA Platform Capabilities with Acquisition of DTx Pharma". Basel. 2023-07-17
AATec Medical GmbH. (7/17/23). "Press Release: AATec Medical Announces Its Launch with EUR 2.7 Million in Seed Financing to Unlock the Therapeutic Potential of Alpha-1 Antitrypsin". Munich. 2023-07-17
High-Tech Gründerfonds Management GmbH. (7/14/23). "Press Release: Pioneering Research Projects at the 8th Life Science Pitch Day at the IZB". Martinsried. 2023-07-14
CureVac N.V.. (7/14/23). "Press Release: CureVac Announces Update to the Management Team". Tübingen & Boston, MA. 2023-07-14
BioGeneration Ventures B.V.. (7/13/23). "Press Release: BioGeneration Ventures Closes BGV Fund V at €150 Million". Naarden. 2023-07-13
Merck KGaA. (7/12/23). "Press Release: Merck Invests € 23 Million to Expand Cell Culture Media Production in Kansas, USA". Darmstadt. 2023-07-12
Tenpoint Therapeutics Ltd.. (7/12/23). "Press Release: Tenpoint Therapeutics Launches with $70 Million Series A Financing to Reverse Vision Loss Through Engineered Cell-based Therapeutics and In Vivo Reprogramming". London. 2023-07-12
SparingVision S.A.S.. (7/12/23). "Press Release: SparingVision Sells Ex Vivo GIRK Technology to Tenpoint Therapeutics". Paris. 2023-07-12
High-Tech Gründerfonds Management GmbH. (7/12/23). "Press Release: Vertama Raises Seven-figure Seed Funding for Efficient, Digital Healthcare Processes". Berlin. 2023-07-12
next pagenext page 1 2 3 ... 53 54 55  next pagenext page


Picture Stier Group MIXiii Lifescience Healthtech Conference 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group Biotech Showcase 2024 San Francisco 650x300px

» top